TCT-418 24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension – First Results From The Halle-RDN-Registry

Despite the widely discussed unfavorable outcome of the SymplicityTM HTN 3 trial, several independent trials and registries have shown a blood pressure (BP) lowering effect in the majority of patients treated with a renal denervation (RDN) device. So far, current available data are almost entirely